Alzinova AB (publ) (STO:ALZ)
0.6000
+0.0140 (2.39%)
Mar 4, 2026, 5:29 PM CET
Alzinova AB Market Cap
Alzinova AB has a market cap or net worth of 62.59 million as of March 4, 2026. Its market cap has decreased by -77.50% in one year.
Market Cap
62.59M
Enterprise Value
62.91M
Revenue
26.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since November 25, 2015, Alzinova AB's market cap has increased from 57.35M to 62.59M, an increase of 9.14%. That is a compound annual growth rate of 0.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 62.59M | -27.62% |
| Dec 30, 2025 | 86.48M | -71.97% |
| Dec 30, 2024 | 308.51M | 128.27% |
| Dec 29, 2023 | 135.15M | 50.50% |
| Dec 30, 2022 | 89.80M | -11.61% |
| Dec 30, 2021 | 101.60M | -13.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 102.36M |
| Biovica International AB | 101.59M |
| Alligator Bioscience AB | 97.39M |
| Scandinavian ChemoTech AB | 90.36M |
| Biosergen AB | 90.17M |
| OncoZenge AB | 82.32M |
| Spago Nanomedical AB | 77.73M |
| Pila Pharma AB | 54.18M |